160 related articles for article (PubMed ID: 20595157)
21. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH
Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798
[TBL] [Abstract][Full Text] [Related]
22. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
[TBL] [Abstract][Full Text] [Related]
23. Predictors of long-term survival in patients with chronic obstructive pulmonary disease.
Yildiz OA; Onen ZP; Sen E; Gulbay BE; Kose K; Saryal S; Karabiyikoglu G
Saudi Med J; 2006 Dec; 27(12):1866-72. PubMed ID: 17143366
[TBL] [Abstract][Full Text] [Related]
24. Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score.
Chang CL; Sullivan GD; Karalus NC; Mills GD; McLachlan JD; Hancox RJ
Respirology; 2011 Jan; 16(1):146-51. PubMed ID: 20920140
[TBL] [Abstract][Full Text] [Related]
25. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
[TBL] [Abstract][Full Text] [Related]
26. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
[TBL] [Abstract][Full Text] [Related]
27. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation.
Martinez-Rivera C; Portillo K; Muñoz-Ferrer A; Martínez-Ortiz ML; Molins E; Serra P; Ruiz-Manzano J; Morera J
COPD; 2012 Jun; 9(3):243-50. PubMed ID: 22360381
[TBL] [Abstract][Full Text] [Related]
28. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
Garcia-Aymerich J; Gómez FP; Benet M; Farrero E; Basagaña X; Gayete À; Paré C; Freixa X; Ferrer J; Ferrer A; Roca J; Gáldiz JB; Sauleda J; Monsó E; Gea J; Barberà JA; Agustí À; Antó JM;
Thorax; 2011 May; 66(5):430-7. PubMed ID: 21177668
[TBL] [Abstract][Full Text] [Related]
29. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
[TBL] [Abstract][Full Text] [Related]
30. The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology.
Sadatsafavi M; Xie H; Etminan M; Johnson K; FitzGerald JM;
PLoS One; 2018; 13(1):e0191243. PubMed ID: 29351331
[TBL] [Abstract][Full Text] [Related]
31. Trends in the lifetime risk of COPD exacerbation requiring hospitalisation.
Lykkegaard J; dePont Christensen R; Davidsen JR; Støvring H; Andersen M; Søndergaard J
Eur Respir J; 2013 Oct; 42(4):964-71. PubMed ID: 23429915
[TBL] [Abstract][Full Text] [Related]
32. Gender differences in survival following hospitalisation for COPD.
Gonzalez AV; Suissa S; Ernst P
Thorax; 2011 Jan; 66(1):38-42. PubMed ID: 21113016
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting survival of hospitalised patients with COPD.
Gunen H; Hacievliyagil SS; Kosar F; Mutlu LC; Gulbas G; Pehlivan E; Sahin I; Kizkin O
Eur Respir J; 2005 Aug; 26(2):234-41. PubMed ID: 16055870
[TBL] [Abstract][Full Text] [Related]
34. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
[TBL] [Abstract][Full Text] [Related]
35. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
36. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
37. The prognostic variables predictive of mortality in patients with an exacerbation of COPD admitted to the ICU: an integrative review.
Messer B; Griffiths J; Baudouin SV
QJM; 2012 Feb; 105(2):115-26. PubMed ID: 22071965
[TBL] [Abstract][Full Text] [Related]
38. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.
van Gestel YR; Hoeks SE; Sin DD; Simsek C; Welten GM; Schouten O; Stam H; Mertens FW; van Domburg RT; Poldermans D
Am J Cardiol; 2008 Jul; 102(2):192-6. PubMed ID: 18602520
[TBL] [Abstract][Full Text] [Related]
39. The impact of using different symptom-based exacerbation algorithms in patients with COPD.
Trappenburg JC; van Deventer AC; Troosters T; Verheij TJ; Schrijvers AJ; Lammers JW; Monninkhof EM
Eur Respir J; 2011 May; 37(5):1260-8. PubMed ID: 21177839
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
Wilson KC; Krishnan JA; Sliwinski P; Criner GJ; Miravitlles M; Hurst JR; Calverley PMA; Albert RK; Rigau D; Tonia T; Vestbo J; Papi A; Rabe KF; Anzueto A; Wedzicha JA
Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326324
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
